Dr. Schwartz, a board-certified gastroenterologist, has experience with more than 1,000 clinical trials in various specialties.
“Dr. Schwartz brings to the company a unique combination of medical practice and relevant commercial experience relating to specialty biologics that will add depth of knowledge to what is already a best-in-class contract commercial operations team,” said Stephen Cichy, founder and managing director of Monarch.
More articles on gastroenterology:
Dr. John Mitchell elected to BCBS of Nebraska board
Avantis Medical Systems submits 510(k) application for colonoscopy device
New guidelines suggest CRC patients undergo postoperative colonoscopy
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.